No image available for this title

LITERATURE

Efectiveness of gliclazide MR 60 mg in the management of type 2 diabetes: analyses from the EASYDia trial


Although the number of antihyperglycemic agents has expanded signifcantly, sulfonylureas (in particular gliclazide) remain an important option because of a variety of patient and health system factors. The large, real
world, observational, and international EASYDia trial evaluated the efectiveness of gliclazide modifed release (MR)
60 mg in individuals with type 2 diabetes with a broad range of diabetes history, body mass index (BMI) and background antihyperglycemic treatment


Availability

Fonylin MR-002Available

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
Diabetol Metab Syndr (2018) 10:30
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous